Scientific Resources
Our next-generation diagnostic assays have generated novel insights across a broad range of clinical applications.
Access our presentations, publications, and more to see how we’re unlocking the full potential of precision genomics.
Found 65 Results
High rates of undetectable MRD by PhasED-Seq on interim and end of treatment timepoints in untreated advanced stage CHL treated with pembrolizumab + AVD
December 12, 2024 | Poster
The role of MRD-based recurrence detection in early stage lung and breast cancer
November 20, 2024 | Video
Ultra-sensitive ctDNA detection and monitoring in early breast cancer using PhasED-Seq
September 16, 2024 | Poster
Analytical Validation of a Circulating Tumor DNA Assay using PhasED-Seq Technology for Detecting Residual Disease in B-Cell Malignancies
August 9, 2024 | Manuscript
Response-adapted treatment with mosunetuzumab with or without obinutuzumab andpolatuzumab vedotin in treatment naïve follicular and marginal zone lymphoma: interim resultsand PhasED-Seq MRD analysis
June 17, 2024 | Poster
Ultrasensitive circulating tumor DNA (ctDNA) minimal residual disease (MRD) detection in early stage non-small cell lung cancer (NSCLC).
June 5, 2024 | Poster